nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PTGS2—bone cancer	0.269	1	CbGaD
Sulfasalazine—SLC46A1—Methotrexate—bone cancer	0.22	0.425	CbGbCtD
Sulfasalazine—ABCC2—Carboplatin—bone cancer	0.0416	0.0804	CbGbCtD
Sulfasalazine—ABCG2—Carboplatin—bone cancer	0.0376	0.0727	CbGbCtD
Sulfasalazine—ABCC2—Cisplatin—bone cancer	0.0356	0.0687	CbGbCtD
Sulfasalazine—PTGS2—Cisplatin—bone cancer	0.0351	0.0679	CbGbCtD
Sulfasalazine—TBXAS1—hip joint—bone cancer	0.0326	0.287	CbGeAlD
Sulfasalazine—ABCG2—Cisplatin—bone cancer	0.0322	0.0621	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—bone cancer	0.0263	0.0507	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—bone cancer	0.0238	0.046	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—bone cancer	0.0231	0.0446	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—bone cancer	0.0215	0.0416	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—bone cancer	0.0209	0.0403	CbGbCtD
Sulfasalazine—TBXAS1—hip—bone cancer	0.0201	0.177	CbGeAlD
Sulfasalazine—TBXAS1—knee—bone cancer	0.00987	0.0868	CbGeAlD
Sulfasalazine—TBXAS1—leg—bone cancer	0.00541	0.0476	CbGeAlD
Sulfasalazine—TBXAS1—forelimb—bone cancer	0.00537	0.0473	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—bone cancer	0.00483	0.0425	CbGeAlD
Sulfasalazine—TBXAS1—appendage—bone cancer	0.00415	0.0365	CbGeAlD
Sulfasalazine—Vismodegib—SMO—bone cancer	0.00369	0.667	CrCbGaD
Sulfasalazine—PPARG—periosteum—bone cancer	0.00256	0.0225	CbGeAlD
Sulfasalazine—PPARG—leg—bone cancer	0.00204	0.018	CbGeAlD
Sulfasalazine—PPARG—forelimb—bone cancer	0.00203	0.0178	CbGeAlD
Sulfasalazine—PPARG—hindlimb—bone cancer	0.00182	0.016	CbGeAlD
Sulfasalazine—PPARG—appendage—bone cancer	0.00156	0.0138	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—bone cancer	0.00142	0.0125	CbGeAlD
Sulfasalazine—PTGS2—periosteum—bone cancer	0.00131	0.0115	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—bone cancer	0.00118	0.0104	CbGeAlD
Sulfasalazine—CHUK—connective tissue—bone cancer	0.00105	0.00928	CbGeAlD
Sulfasalazine—PTGS2—leg—bone cancer	0.00104	0.00918	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—bone cancer	0.000992	0.00873	CbGeAlD
Sulfasalazine—ACAT1—tendon—bone cancer	0.000973	0.00857	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—bone cancer	0.000943	0.0083	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—bone cancer	0.000939	0.00826	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—bone cancer	0.000931	0.0082	CbGeAlD
Sulfasalazine—PTGS2—cartilage tissue—bone cancer	0.000917	0.00807	CbGeAlD
Sulfasalazine—TBXAS1—tendon—bone cancer	0.000813	0.00716	CbGeAlD
Sulfasalazine—PTGS2—appendage—bone cancer	0.000799	0.00703	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—bone cancer	0.000788	0.00694	CbGeAlD
Sulfasalazine—SLC46A1—tendon—bone cancer	0.000725	0.00638	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—bone cancer	0.000717	0.00631	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—bone cancer	0.000699	0.00615	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—bone cancer	0.000594	0.00523	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—bone cancer	0.000576	0.00507	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—bone cancer	0.000565	0.102	CrCbGaD
Sulfasalazine—IKBKB—tendon—bone cancer	0.000493	0.00434	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—bone cancer	0.000481	0.0869	CrCbGaD
Sulfasalazine—PPARG—connective tissue—bone cancer	0.000446	0.00393	CbGeAlD
Sulfasalazine—Vismodegib—CYP3A4—bone cancer	0.00043	0.0778	CrCbGaD
Sulfasalazine—ALOX5—bone marrow—bone cancer	0.000396	0.00348	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP3A4—bone cancer	0.000364	0.0658	CrCbGaD
Sulfasalazine—PPARG—tendon—bone cancer	0.000307	0.0027	CbGeAlD
Sulfasalazine—PPARG—bone marrow—bone cancer	0.000297	0.00261	CbGeAlD
Sulfasalazine—ABCC2—tendon—bone cancer	0.00027	0.00237	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—bone cancer	0.000239	0.0021	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—bone cancer	0.000228	0.00201	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—bone cancer	0.00019	0.00168	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—bone cancer	0.00019	0.00167	CbGeAlD
Sulfasalazine—PTGS1—tendon—bone cancer	0.000164	0.00144	CbGeAlD
Sulfasalazine—PTGS1—spinal cord—bone cancer	0.000158	0.00139	CbGeAlD
Sulfasalazine—PTGS2—tendon—bone cancer	0.000157	0.00138	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—bone cancer	0.000152	0.00134	CbGeAlD
Sulfasalazine—PTGS2—spinal cord—bone cancer	0.000151	0.00133	CbGeAlD
Sulfasalazine—CHUK—Signaling by ERBB4—MDM2—bone cancer	6.82e-05	0.000722	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—JUN—bone cancer	6.82e-05	0.000721	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—BRAF—bone cancer	6.81e-05	0.000721	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	6.79e-05	0.000719	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NDUFA12—bone cancer	6.76e-05	0.000715	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—CYP3A4—bone cancer	6.69e-05	0.000708	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—bone cancer	6.68e-05	0.000706	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CDK4—bone cancer	6.67e-05	0.000706	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—EGFR—bone cancer	6.62e-05	0.000701	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—DHFR—bone cancer	6.59e-05	0.000697	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—GSTP1—bone cancer	6.54e-05	0.000692	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—MDM2—bone cancer	6.51e-05	0.000689	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—MDM2—bone cancer	6.48e-05	0.000686	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—EGFR—bone cancer	6.46e-05	0.000684	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—MDM2—bone cancer	6.45e-05	0.000682	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KIT—bone cancer	6.43e-05	0.000681	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—MDM2—bone cancer	6.42e-05	0.000679	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—EGFR—bone cancer	6.41e-05	0.000679	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—JUN—bone cancer	6.41e-05	0.000678	CbGpPWpGaD
Sulfasalazine—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.4e-05	0.000677	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	6.38e-05	0.000675	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	6.37e-05	0.000674	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	6.33e-05	0.000669	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.31e-05	0.000668	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—JUN—bone cancer	6.3e-05	0.000666	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—bone cancer	6.29e-05	0.000666	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	6.27e-05	0.000663	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NDUFA12—bone cancer	6.26e-05	0.000662	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—JUN—bone cancer	6.19e-05	0.000655	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—GNA11—bone cancer	6.16e-05	0.000651	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—MMP9—bone cancer	6.13e-05	0.000648	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.12e-05	0.000648	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	6.04e-05	0.000639	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—MDM2—bone cancer	6.04e-05	0.000639	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—MDM2—bone cancer	6.04e-05	0.000639	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NDUFA12—bone cancer	6.01e-05	0.000636	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—MDM2—bone cancer	5.98e-05	0.000633	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—JUN—bone cancer	5.96e-05	0.000631	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—MDM2—bone cancer	5.93e-05	0.000628	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—MDM2—bone cancer	5.91e-05	0.000625	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—RB1—bone cancer	5.8e-05	0.000614	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	5.77e-05	0.000611	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	5.74e-05	0.000607	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—GSTP1—bone cancer	5.72e-05	0.000605	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—JUN—bone cancer	5.71e-05	0.000604	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—bone cancer	5.7e-05	0.000603	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.68e-05	0.000601	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—JUN—bone cancer	5.61e-05	0.000594	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.6e-05	0.000593	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—MDM2—bone cancer	5.59e-05	0.000591	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—CYP3A4—bone cancer	5.58e-05	0.000591	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.55e-05	0.000588	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.48e-05	0.00058	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	5.48e-05	0.000579	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—NR1I2—bone cancer	5.39e-05	0.00057	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—bone cancer	5.35e-05	0.000566	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	5.35e-05	0.000566	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	5.25e-05	0.000555	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ATF1—bone cancer	5.23e-05	0.000554	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KIT—bone cancer	5.22e-05	0.000553	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NT5C3A—bone cancer	5.19e-05	0.000549	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—JUN—bone cancer	5.16e-05	0.000546	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—MDM2—bone cancer	5.07e-05	0.000536	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—JUN—bone cancer	5.05e-05	0.000534	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ENO2—bone cancer	5.03e-05	0.000533	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NT5C3A—bone cancer	4.98e-05	0.000527	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—JUN—bone cancer	4.96e-05	0.000525	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—EGFR—bone cancer	4.95e-05	0.000524	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.94e-05	0.000523	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—BRAF—bone cancer	4.91e-05	0.000519	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NDUFA12—bone cancer	4.77e-05	0.000505	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—GSTP1—bone cancer	4.77e-05	0.000505	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	4.76e-05	0.000504	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ATF1—bone cancer	4.75e-05	0.000502	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KIT—bone cancer	4.74e-05	0.000501	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—EGFR—bone cancer	4.74e-05	0.000501	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—bone cancer	4.69e-05	0.000496	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—DHFR—bone cancer	4.67e-05	0.000494	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—EGFR—bone cancer	4.66e-05	0.000493	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KIT—bone cancer	4.66e-05	0.000493	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.54e-05	0.00048	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NDUFA12—bone cancer	4.48e-05	0.000474	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PTGS2—bone cancer	4.47e-05	0.000473	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—BRAF—bone cancer	4.45e-05	0.000471	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—EGFR—bone cancer	4.45e-05	0.000471	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—EGFR—bone cancer	4.43e-05	0.000469	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—EGFR—bone cancer	4.41e-05	0.000466	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—EGFR—bone cancer	4.39e-05	0.000464	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—BRAF—bone cancer	4.38e-05	0.000463	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GNA11—bone cancer	4.36e-05	0.000462	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	4.32e-05	0.000457	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MMP9—bone cancer	4.18e-05	0.000443	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	4.13e-05	0.000437	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—EGFR—bone cancer	4.13e-05	0.000437	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—EGFR—bone cancer	4.13e-05	0.000437	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—MDM2—bone cancer	4.11e-05	0.000435	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—EGFR—bone cancer	4.09e-05	0.000433	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—EGFR—bone cancer	4.05e-05	0.000429	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—EGFR—bone cancer	4.04e-05	0.000427	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—EIF2S1—bone cancer	3.98e-05	0.000421	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CYP3A4—bone cancer	3.96e-05	0.000419	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NT5C3A—bone cancer	3.96e-05	0.000418	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.94e-05	0.000416	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—bone cancer	3.93e-05	0.000416	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	3.92e-05	0.000415	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—EGFR—bone cancer	3.9e-05	0.000413	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.88e-05	0.000411	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—EGFR—bone cancer	3.82e-05	0.000404	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MET—bone cancer	3.82e-05	0.000404	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CDK4—bone cancer	3.82e-05	0.000404	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RGS1—bone cancer	3.8e-05	0.000402	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GRM4—bone cancer	3.8e-05	0.000402	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	3.74e-05	0.000396	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MDM2—bone cancer	3.73e-05	0.000395	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NT5C3A—bone cancer	3.72e-05	0.000393	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MDM2—bone cancer	3.67e-05	0.000388	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	3.65e-05	0.000387	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTGS2—bone cancer	3.54e-05	0.000374	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ENO2—bone cancer	3.49e-05	0.00037	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—EGFR—bone cancer	3.46e-05	0.000366	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—EZH2—bone cancer	3.46e-05	0.000366	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GRM4—bone cancer	3.44e-05	0.000364	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RGS1—bone cancer	3.44e-05	0.000364	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTGS2—bone cancer	3.39e-05	0.000359	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GSTP1—bone cancer	3.38e-05	0.000358	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—EGFR—bone cancer	3.38e-05	0.000358	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.37e-05	0.000356	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—bone cancer	3.33e-05	0.000353	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GRM1—bone cancer	3.29e-05	0.000348	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—bone cancer	3.28e-05	0.000347	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.26e-05	0.000345	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—DHFR—bone cancer	3.24e-05	0.000343	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—bone cancer	3.21e-05	0.000339	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP2—bone cancer	3.18e-05	0.000337	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ENO2—bone cancer	3.12e-05	0.00033	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ATF1—bone cancer	3.05e-05	0.000323	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GRM1—bone cancer	2.98e-05	0.000316	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KIT—bone cancer	2.98e-05	0.000315	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL3—bone cancer	2.97e-05	0.000315	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTGS2—bone cancer	2.96e-05	0.000313	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.93e-05	0.00031	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—DHFR—bone cancer	2.89e-05	0.000306	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIT—bone cancer	2.86e-05	0.000303	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—bone cancer	2.84e-05	0.0003	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—EGFR—bone cancer	2.81e-05	0.000297	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ATF1—bone cancer	2.76e-05	0.000293	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KIT—bone cancer	2.7e-05	0.000286	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GNA11—bone cancer	2.7e-05	0.000286	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL3—bone cancer	2.7e-05	0.000285	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIT—bone cancer	2.59e-05	0.000274	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—EGFR—bone cancer	2.55e-05	0.00027	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EGFR—bone cancer	2.51e-05	0.000265	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—bone cancer	2.47e-05	0.000262	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ENO2—bone cancer	2.45e-05	0.00026	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CYP3A4—bone cancer	2.45e-05	0.000259	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.44e-05	0.000258	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—bone cancer	2.39e-05	0.000253	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFBR2—bone cancer	2.35e-05	0.000248	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MDM2—bone cancer	2.35e-05	0.000248	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SMO—bone cancer	2.32e-05	0.000245	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.3e-05	0.000243	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—DHFR—bone cancer	2.28e-05	0.000241	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ENO2—bone cancer	2.27e-05	0.00024	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—MDM2—bone cancer	2.25e-05	0.000238	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ENO2—bone cancer	2.18e-05	0.000231	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MDM2—bone cancer	2.13e-05	0.000225	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GNA11—bone cancer	2.13e-05	0.000225	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GNA11—bone cancer	2.12e-05	0.000224	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—DHFR—bone cancer	2.11e-05	0.000223	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SMO—bone cancer	2.1e-05	0.000222	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSTP1—bone cancer	2.09e-05	0.000222	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ENO2—bone cancer	2.07e-05	0.000219	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—MDM2—bone cancer	2.04e-05	0.000216	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—JUN—bone cancer	2.04e-05	0.000216	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—DHFR—bone cancer	2.02e-05	0.000214	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ATF1—bone cancer	1.97e-05	0.000209	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GNA11—bone cancer	1.97e-05	0.000208	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EGFR—bone cancer	1.93e-05	0.000205	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.93e-05	0.000204	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.93e-05	0.000204	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GNA11—bone cancer	1.92e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL3—bone cancer	1.92e-05	0.000203	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—DHFR—bone cancer	1.92e-05	0.000203	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.92e-05	0.000203	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GNA11—bone cancer	1.89e-05	0.0002	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—JUN—bone cancer	1.85e-05	0.000196	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ATF1—bone cancer	1.79e-05	0.000189	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CYP3A4—bone cancer	1.79e-05	0.000189	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—bone cancer	1.75e-05	0.000185	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL3—bone cancer	1.74e-05	0.000184	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIT—bone cancer	1.74e-05	0.000184	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ENO2—bone cancer	1.73e-05	0.000183	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYP3A4—bone cancer	1.72e-05	0.000182	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.71e-05	0.000181	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTP1—bone cancer	1.65e-05	0.000175	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFBR2—bone cancer	1.64e-05	0.000174	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ENO2—bone cancer	1.63e-05	0.000172	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—DHFR—bone cancer	1.61e-05	0.00017	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EGFR—bone cancer	1.6e-05	0.00017	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KIT—bone cancer	1.6e-05	0.00017	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIT—bone cancer	1.57e-05	0.000166	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1R—bone cancer	1.55e-05	0.000164	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—EGFR—bone cancer	1.54e-05	0.000163	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTP1—bone cancer	1.53e-05	0.000162	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—DHFR—bone cancer	1.51e-05	0.00016	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—BRAF—bone cancer	1.51e-05	0.000159	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNA11—bone cancer	1.5e-05	0.000159	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFBR2—bone cancer	1.49e-05	0.000158	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTP1—bone cancer	1.47e-05	0.000155	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EGFR—bone cancer	1.45e-05	0.000154	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNA11—bone cancer	1.41e-05	0.000149	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1R—bone cancer	1.4e-05	0.000148	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—bone cancer	1.4e-05	0.000148	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFBR2—bone cancer	1.39e-05	0.000147	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MDM2—bone cancer	1.37e-05	0.000145	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP3A4—bone cancer	1.36e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.28e-05	0.000135	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MDM2—bone cancer	1.26e-05	0.000134	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MDM2—bone cancer	1.24e-05	0.000131	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—bone cancer	1.22e-05	0.000129	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—JUN—bone cancer	1.19e-05	0.000126	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTP1—bone cancer	1.16e-05	0.000123	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—bone cancer	1.12e-05	0.000119	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—bone cancer	1.09e-05	0.000116	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—bone cancer	1.09e-05	0.000115	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—bone cancer	1.08e-05	0.000114	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—bone cancer	1.05e-05	0.000112	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—bone cancer	1.02e-05	0.000108	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—bone cancer	9.56e-06	0.000101	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—bone cancer	9.49e-06	0.0001	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—bone cancer	9.34e-06	9.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—bone cancer	8.92e-06	9.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—bone cancer	8.84e-06	9.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—bone cancer	8.62e-06	9.12e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—bone cancer	8.54e-06	9.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—bone cancer	8.47e-06	8.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—bone cancer	8.01e-06	8.48e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—bone cancer	7.91e-06	8.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—bone cancer	7.68e-06	8.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—bone cancer	7.6e-06	8.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—bone cancer	7.47e-06	7.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—bone cancer	7.47e-06	7.91e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—bone cancer	6.96e-06	7.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—bone cancer	6.78e-06	7.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—bone cancer	6.04e-06	6.39e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—bone cancer	5.67e-06	6e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—bone cancer	5.47e-06	5.79e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—bone cancer	5.11e-06	5.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—bone cancer	5.07e-06	5.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—bone cancer	4.6e-06	4.86e-05	CbGpPWpGaD
